Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients

International Journal of Antimicrobial Agents

Volumn 38, Issue 2, 2011, Pages 152-156

  Chaijamorn, Weerachai ^a   Jitsurong, Arnurai ^b   Wiwattanawongsa, Kamonthip ^b   Wanakamanee, Usanee ^b   Dandecha, Phongsak ^b  

^a SIAM UNIVERSITY   (Thailand)

^b PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

Clearance; Continuous venovenous haemofiltration (CVVH); Critically ill patients; Pharmacokinetics; Vancomycin

Indexed keywords

VANCOMYCIN;

ACUTE KIDNEY FAILURE; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; ARTIFICIAL KIDNEY; BACTERIAL ENDOCARDITIS; CELLULITIS; CLINICAL ARTICLE; CONTINUOUS HEMOFILTRATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; HUMAN; MAINTENANCE DRUG DOSE; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPTIC SHOCK; STEADY STATE; UNSPECIFIED SIDE EFFECT; VENTILATOR ASSOCIATED PNEUMONIA; WOUND INFECTION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CRITICAL ILLNESS; HEMODIAFILTRATION; HUMANS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; PROSPECTIVE STUDIES; VANCOMYCIN;

EID: 79959732600     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2011.04.010     Document Type: Article

References (20)

1. S.J. Vandecasteele, and A.S. De Vriese Recent changes in vancomycin use in renal failure Kidney Int 77 2010 760 764
2. G.R. Matzke Vancomycin W.E. Evans, J.J. Schentag, W.J. Jusco, Applied pharmacokinetics: principles of therapeutic drug monitoring. 3rd ed. 1992 Applied Therapeutics Inc. Spokane, WA p. 15/1-15/31
3. P. Llopis-Salvia, and N.V. Jiménez-Torres Population pharmacokinetic parameters of vancomycin in critically ill patients J Clin Pharm Ther 31 2006 447 454 (Pubitemid 44337293)
4. F. Pea, P. Viale, and M. Furlanut Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability Clin Pharmacokinet 44 2005 1009 1034 (Pubitemid 41356389)
5. J.A. Roberts, and J. Lipman Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis Clin Pharmacokinet 45 2006 755 773
6. J.A. Roberts, and J. Lipman Pharmacokinetic issues for antibiotics in the critically ill patient Crit Care Med 37 2009 840 851
7. C. Ronco, R. Bellomo, and Z. Ricci Continuous renal replacement therapy in critically ill patients Nephrol Dial Transplant 16 Suppl. 5 2001 67 72 (Pubitemid 32750433)
8. F. Pea, P. Viale, F. Pavan, and M. Furlanut Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy Clin Pharmacokinet 46 2007 997 1038 (Pubitemid 350136909)
9. M. Schetz Drug dosing in continuous renal replacement therapy: general rules Curr Opin Crit Care 13 2007 645 651 (Pubitemid 350059527)
10. R.L. Trotman, J.C. Williamson, D.M. Shoemaker, and W.L. Salzer Antibiotic dosing in critically ill adult patients receiving continuous renal replacement therapy Clin Infect Dis 41 2005 1159 1165
11. D. Kuang, A. Verbine, and C. Ronco Pharmacokinetics and antimicrobial dosing adjustment in critically ill patients during continuous renal replacement therapy Clin Nephrol 67 2007 267 284
12. M. Rybak, B. Lomaestro, J.C. Rotschafer, R. Moellering Jr., W. Craig, and M. Billeter Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists Am J Health Syst Pharm 66 2009 82 98 Erratum in: Am J Health Syst Pharm 2009;66:887
13. M.S. Joy, G.R. Matzke, R.F. Frye, and P.M. Palevsky Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis Am J Kidney Dis 31 1998 1019 1027 (Pubitemid 28265200)
14. F.T.J. Boereboom, F.F.T. Verves, P.J. Blankestijn, T.J.F. Savelkoul, and A. van Dijk Vancomycin clearance during continuous venovenous hemofiltration in critically ill patients Intensive Care Med 25 1999 1100 1104 (Pubitemid 29525065)
15. S. Uchino, L. Cole, H. Morimatsu, D. Goldsmith, and R. Bellomo Clearance of vancomycin during high-volume haemofiltration: impact of pre-dilution Intensive Care Med 28 2002 1664 1667 (Pubitemid 36002520)
16. A.H. Thomson, A.C. Grant, R.S.C. Rodger, and R. Hughes Gentamicin and vancomycin removal by continuous venovenous hemofiltration DICP 25 1991 127 129
17. D.K. Armstrong, H.A. Hidalgo, and M. Eldadah Vancomycin and tobramycin clearance in an infant during continuous hemofiltration Ann Pharmacother 27 1993 224 227 (Pubitemid 23062145)
18. M.Y. Munar, I.C. Doyle, and M.M. Meyer Cyclosporine and vancomycin disposition during continuous venovenous hemofiltration Ann Pharmacother 29 1995 374 377
19. B. Joos, M. Schmidil, and G. Keusch Pharmacokinetics of antimicrobial agents in anuric patients during continuous venovenous hemofiltration Nephrol Dial Transplant 11 1996 1582 1585 (Pubitemid 26252727)
20. W.L. Macias, B.A. Mueller, and S.K. Scarim Vancomycin pharmacokinetics in acute renal failure: preservation of nonrenal clearance Clin Pharmacol Ther 50 1991 688 694